During the past decade, Contra Costa Regional Medical Center conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 78 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 29 clinical trials were completed. i.e. 111.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Contra Costa Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 65 trials, followed by "Alliance for Clinical Trials in Oncology" with 37 trials sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Contra Costa Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 93 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Canadian Cancer Trials Group" with 6 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Contra Costa Regional Medical Center" are "Breast Cancer" (20 trials), "Invasive Breast Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (11 trials), "Lung Cancer" (9 trials) and "Stage IIIA Breast Cancer" (8 trials). Many other conditions were trialed in "Contra Costa Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Contra Costa Regional Medical Center" are "Drug" (123 trials), "Other" (97 trials), "Biological" (53 trials), "Procedure" (33 trials) and "Radiation" (22 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (32 trials), "Questionnaire Administration" (20 trials), "Bevacizumab" (18 trials) and "Paclitaxel" (18 trials). Other intervention names were less common.

The vast majority of trials in "Contra Costa Regional Medical Center" are 121 trials for "All" genders, 33 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Contra Costa Regional Medical Center". undefined are not yet recruiting, 27 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Contra Costa Regional Medical Center, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Contra Costa Regional Medical Center, 7 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".